Brief: Psychemedics adds FDA cleared drugs to testing panels
June 2 (Reuters) - Psychemedics Corp PMD.O : * Announces addition of FDA cleared drugs * Says addition of 2 new drugs to the company's drug testing panels * Addition of oxymorphone was made to synthetic opiate testing panel and d-amphetamine/adderall was added as option to amphetamine panel * Source text for Eikon ID:nPn8dRLrJ * Further company coverage PMD.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Psychemedics
See all newsBrief: Psychemedics Corporation Announces Reverse and Forward Stock Split
Brief: Psychemedics' Board Approves Plan To Cease Registration Of Common Stock
Brief: Psychemedics Corporation Q1 Net Income USD -700 Thousand
Brief: Psychemedics Corporation Q3 Net Income USD -2.099 Million
Brief: Psychemedics Corp Reports First Quarter 2023 Financial Results And Declares Cash Dividend